AMENDMENT AGREEMENT TO PURCHASE AGREEMENTAgreement to Purchase Agreement • July 14th, 2022 • CURO Group Holdings Corp. • Finance services
This Amendment Agreement (this “Amendment”) to the Equity and Asset Purchase Agreement of May 18, 2022 (the “Purchase Agreement”) by and among CURO Intermediate Holdings Corp. (“Seller”), Sparrow Purchaser, LLC (“Purchaser”), and, solely for the purposes of Section 11.17 thereto, CCF Intermediate Holdings LLC (“Purchaser Parent”), is entered into as of July 8, 2022 (the “Effective Date”), by and among Seller, Purchaser and Purchaser Parent. Seller, Purchaser and Purchaser Parent are referred to herein each as a “Party” and together as the “Parties”.
AMENDMENT AGREEMENT TO PURCHASE AGREEMENTAgreement to Purchase Agreement • March 15th, 2006 • Avant Immunotherapeutics Inc • In vitro & in vivo diagnostic substances • New York
THIS AMENDMENT AGREEMENT TO PURCHASE AGREEMENT (this “Amendment”) is made and entered into as of March 14, 2006 between AVANT Immunotherapeutics, Inc., a Delaware corporation (“AVANT”), and PRF Vaccine Holdings LLC, a Delaware limited liability company (“PRF”), an Affiliate of Paul Royalty Fund II, L.P., a Delaware limited partnership.
